Metadata Search Funding Data Link References Status API Help
Facet browsing currently unavailable
Page 1 of 4050 results
Sort by: relevance publication year
Showing results for ISSN matching 2059-7029

Concerning the article by Louveauet al “Clinical value of early detection of circulating tumour DNA BRAFV600mut in patients with metastatic melanoma treated with a BRAF inhibitor”

JOURNAL ARTICLE published 2017 in ESMO Open

Authors: Caroline Robert

https://doi.org/10.1136/esmoopen-2017-000207 Actions

PO-482 Efficacy of inhibition of BAD Ser99 phosphorylation by a novel small molecule in cisplatin resistant ovarian cancer

JOURNAL ARTICLE published June 2018 in ESMO Open

Authors: Y. Wang | Q.Y. Chong | V. Pandey | S. Basappa | M. Choolani | R.Y.J. Huang | P.E. Lobie

https://doi.org/10.1136/esmoopen-2018-eacr25.500 Actions

PO-307 Paradoxical decrease in H2AFX copy number yet increasing mRNA expression in human breast cancer

JOURNAL ARTICLE published June 2018 in ESMO Open

Authors: J. Passos | A. Flaus | H. Dodson

https://doi.org/10.1136/esmoopen-2018-eacr25.337 Actions

New horizon in breast cancer therapy: highlights from the European Society for Medical Oncology

JOURNAL ARTICLE published 2017 in ESMO Open

Authors: Elżbieta Senkus

https://doi.org/10.1136/esmoopen-2017-000204 Actions

PO-476 Increased ERK phosphorylation as a candidate driver of resistance to the experimental cancer drug AT13148

JOURNAL ARTICLE published June 2018 in ESMO Open

Authors: N. Breeds | D. Akan | M. Walton | M. Garrett

https://doi.org/10.1136/esmoopen-2018-eacr25.495 Actions

PO-439 Enhanced cytotoxic and chemosensitizing effects of conjugated small gold nanoparticles

JOURNAL ARTICLE published June 2018 in ESMO Open

Authors: S.E. El Feky | S.M. Moussa | M.H. Moustafa | N.N. Rahil | N.A. Abd El Moneim

https://doi.org/10.1136/esmoopen-2018-eacr25.463 Actions

PO-121 ALK dependant phosphoproteome and gene expression profiling of neuroblastoma cells

JOURNAL ARTICLE published June 2018 in ESMO Open

Authors: J. Szydzik | J. Van den Eynden | G. Umapathy | A. Ashouri | D. Cervantes-Madrid | R. Palmer | B. Hallberg | E. Larsson Lekholm | K. Ruuth

https://doi.org/10.1136/esmoopen-2018-eacr25.162 Actions

PO-496 Loss of PARG drives PARP inhibitor resistance in BRCA2-deficient mouse mammary tumours

JOURNAL ARTICLE published June 2018 in ESMO Open

Authors: E. Gogola | J. Jonkers | S. Rottenberg

https://doi.org/10.1136/esmoopen-2018-eacr25.513 Actions

PO-050 Long noncoding RNA, ANRIL positively regulates cell proliferation in a P15/P16-dependent and -independent manners

JOURNAL ARTICLE published June 2018 in ESMO Open

Authors: Y. Kotake

https://doi.org/10.1136/esmoopen-2018-eacr25.94 Actions

Table of Contents

JOURNAL ARTICLE published October 2023 in ESMO Open

https://doi.org/10.1016/s2059-7029(23)01296-6 Actions

Does the RAPIDO trial suggest a benefit of post-operative chemotherapy after preoperative chemoradiation in rectal cancer? No, it does not.

JOURNAL ARTICLE published October 2023 in ESMO Open

Authors: J. Socha | W. Michalski | K. Bujko

https://doi.org/10.1016/j.esmoop.2023.101644 Actions

Authors’ reply—Does the RAPIDO trial suggest a benefit of post-operative chemotherapy after preoperative chemoradiation in rectal cancer? No, it does not

JOURNAL ARTICLE published October 2023 in ESMO Open

Authors: W.H. Zwart | E.A. Dijkstra | H. Putter | C.A.M. Marijnen | P.J. Nilsson | C.J.H. van de Velde | B. van Etten | G.A.P. Hospers | B. Glimelius

https://doi.org/10.1016/j.esmoop.2023.101645 Actions

The paradigm shift to precision oncology between political will and cultural acceptance

JOURNAL ARTICLE published October 2023 in ESMO Open

Authors: E. Rassy | J.-M. Heard | F. Andre

https://doi.org/10.1016/j.esmoop.2023.101622 Actions

Are ERBB2 mutations a ‘ready for routine use’ target in patients with metastatic breast cancer?

JOURNAL ARTICLE published October 2023 in ESMO Open

Authors: T. Grinda | B. Pistilli

https://doi.org/10.1016/j.esmoop.2023.101832 Actions

Prognostic value of comorbidities in older patients with cancer: the ELCAPA cohort study

JOURNAL ARTICLE published October 2023 in ESMO Open

Authors: M.-A. Benderra | A.G. Serrano | E. Paillaud | C.M. Tapia | T. Cudennec | C. Chouaïd | E. Lorisson | A. de la Taille | M. Laurent | E. Brain | M. Bringuier | J. Gligorov | P. Caillet | F. Canoui-Poitrïne

https://doi.org/10.1016/j.esmoop.2023.101831 Actions

PO-312 Longitudinal transcriptomics reveals heterogeneous dynamics through the course of disease and therapy in breast cancer

JOURNAL ARTICLE published June 2018 in ESMO Open

Authors: M. Dadiani | G. Friedlander | G. Perry | N. Lahat-Balint | I. Marin | A. Pavlovski | I. Barshack | E. Nili Gal-Yam | B. Kaufman

https://doi.org/10.1136/esmoopen-2018-eacr25.342 Actions

PO-510 XRCC6BP1: a novel role in the DNA repair of platinum resistant NSCLC cells

JOURNAL ARTICLE published June 2018 in ESMO Open

Authors: M. Barr | S. Singh | R. Farrell | E. Foley | Y. He | S. Nicholson | N. Leonard | L. Brady | S. Cuffe | S. Finn

https://doi.org/10.1136/esmoopen-2018-eacr25.1011 Actions

PO-175 Effects of trastuzumab and afatinib on kinase activity in gastric cancer cell lines

JOURNAL ARTICLE published June 2018 in ESMO Open

Authors: S. Keller | G. Zwingenberger | K. Ebert | J. Hasenauer | J. Wasmuth | D. Maier | I. Haffner | K. Schierle | G. Weirich | B. Luber

https://doi.org/10.1136/esmoopen-2018-eacr25.697 Actions

PO-319 Mutational signatures of 1,2-dichloropropane and dichloromethane identified in mouse carcinogenicity assays

JOURNAL ARTICLE published June 2018 in ESMO Open

Authors: S. Lueong | S. Villar | V. Cahais | A. Heguy | H. Wanibuchi | M. Gi | Y. Totsuka | R. Herbert | J. Zavadil | M. Olivier

https://doi.org/10.1136/esmoopen-2018-eacr25.349 Actions

Po-327 Modelling intratumor heterogeneity through CRISPR-barcodes

JOURNAL ARTICLE published June 2018 in ESMO Open

Authors: L. Grumolato | A. Guernet | D. Alexandre | L. Brunet | M.D.M. Blanquer Rosselló | R. Sachidanandam | S. Aaronson | Y. Anouar

https://doi.org/10.1136/esmoopen-2018-eacr25.840 Actions
Feedback: support@crossref.org